J. T. ten Cate

发表

Subcutaneous Heparin Compared with Continuous Intravenous Heparin Administration in the Initial Treatment of Deep Vein Thrombosis

D. Hommes, A. Bura, L. Mazzolai, 1992, Annals of Internal Medicine.

Activation of coagulation after administration of tumor necrosis factor to normal subjects.

T. van der Poll, H. Büller, J. T. ten Cate, 1990, The New England journal of medicine.

α2-Antiplasmin: Functional Characterization and Metabolism in a Heterozygote Deficient Patient

J. T. ten Cate, E. Knot, R. Lamping, 1986, Thrombosis and Haemostasis.

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

J. E. Doran, T. van der Poll, J. T. ten Cate, 1996, The Journal of experimental medicine.

Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans.

J. T. ten Cate, S. Deventer, G. Pasterkamp, 1996, Blood.

Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis.

M. Kersten, H. Büller, J. T. ten Cate, 1989, Chest.

Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study.

H. Büller, J. T. ten Cate, M. Huisman, 1986, The New England journal of medicine.

Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting.

H. Büller, J. T. ten Cate, M. Huisman, 1989, Archives of internal medicine.

Diagnosis of deep-vein thrombosis using an objective Doppler method.

H. Büller, J. T. ten Cate, P. Prandoni, 1990 .

The effects of antithrombin III, heparin and a novel heparinoid infusions on the bleeding tendency using an experimental model in the rat.

H. Büller, J. T. ten Cate, P. Hobbelen, 1983, Thrombosis research.

Estrogen-induced deficiency and decrease in antithrombin III activity in patients with prostatic cancer.

H. Büller, J. T. ten Cate, N. F. Dabhoiwala, 1982, The Journal of urology.

Diagnostic management of venous thromboembolism.

H. Büller, J. T. ten Cate, E. Van Beek, 1998, Bailliere's clinical haematology.

Deep Vein Thrombosis: New Non-Invasive Diagnostic Tests

J. Hirsh, H. Büller, J. T. ten Cate, 1991, Thrombosis and Haemostasis.

Severe Factor V Deficiency with Prolonged Bleeding Time

J. T. ten Cate, E. V. van Royen, K. Breederveld, 1974, Thrombosis and Haemostasis.

R. Wanders, J. T. ten Cate, R. Schutgens, 1987, Blood.

Prevention of Deep Vein Thrombosis following Total Hip Replacement by Low Molecular Weight Heparinoid

K., H. Büller, J. T. ten Cate, 1992, Thrombosis and Haemostasis.

Differential Effects of Reconstituted High-density Lipoprotein on Coagulation, Fibrinolysis and Platelet Activation during Human Endotoxemia

J. E. Doran, T. van der Poll, J. T. ten Cate, 1997, Thrombosis and Haemostasis.

Diagnosis of recurrent deep vein thrombosis.

H. Büller, J. T. ten Cate, M. Koopman, 1995, Haemostasis.

Lower extremity venography with iohexol: results and complications.

H. Büller, J. T. ten Cate, P. Prandoni, 1990, Radiology.

Comparison of Real-Time B-Mode Ultrasonography and Doppler Ultrasound with Contrast Venography in the Diagnosis of Venous Thrombosis in Symptomatic Outpatients

H. Büller, J. T. ten Cate, P. Prandoni, 1993, Thrombosis and Haemostasis.

A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients.

H. Büller, J. T. ten Cate, A. Turpie, 1993, The New England journal of medicine.

Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.

T. van der Poll, H. Büller, J. T. ten Cate, 1994, The Journal of clinical investigation.

Fibrinolytic response to tumor necrosis factor in healthy subjects

T. van der Poll, H. Büller, J. T. ten Cate, 1991, The Journal of experimental medicine.

Plasminogen Activation In Vivo upon Intravenous Infusion of DDAVP

J. T. ten Cate, C. Hack, M. Levi, 1992, Thrombosis and Haemostasis.

Assessment of the Relative Contribution of Different Protease Inhibitors to the Inhibition of Plasmin In Vivo

J. T. ten Cate, C. Hack, M. Levi, 1993, Thrombosis and Haemostasis.

Coagulation Activation and Tissue Necrosis in Meningococcal Septic Shock: Severely Reduced Protein C Levels Predict a High Mortality

J. T. ten Cate, S. Deventer, S. V. van Deventer, 1995, Thrombosis and Haemostasis.

Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.

M. Prins, H. Büller, J. T. ten Cate, 1992, The New England journal of medicine.

A Comparative Analysis of D-Dimer Assays in Patients with Clinically Suspected Pulmonary Embolism

J. T. ten Cate, A. Sturk, E. Van Beek, 1993, Thrombosis and Haemostasis.

Detection of deep vein thrombosis with impedance plethysmography and real-time compression ultrasonography in hospitalized patients.

H. Büller, J. T. ten Cate, P. Prandoni, 1992, Archives of internal medicine.

Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.

H. Büller, J. T. ten Cate, A. Sturk, 1990, The New England journal of medicine.

Antithrombotic Drugs in the Primary Medical Management of Intermittent Claudication: A Meta-analysis

M. Prins, H. Büller, J. T. ten Cate, 1999, Thrombosis and Haemostasis.

The value of lung scintigraphy in the diagnosis of pulmonary embolism

H. Büller, J. T. ten Cate, E. Beek, 1993, European Journal of Nuclear Medicine.

A normal perfusion lung scan in patients with clinically suspected pulmonary embolism. Frequency and clinical validity.

H. Büller, J. T. ten Cate, E. Van Beek, 1995, Chest.

Diagnostic Utility of Ultrasonography of Leg Veins in Patients Suspected of Having Pulmonary Embolism

J. T. ten Cate, E. Van Beek, H. Buller, 1997, Annals of Internal Medicine.

A survey of the diagnostic and therapeutic management of patients with suspected pulmonary embolism in the Netherlands.

H. Büller, J. T. ten Cate, E. Van Beek, 1997, The Netherlands journal of medicine.

Ventilation-Perfusion Lung Scanning and the Diagnosis of Pulmonary Embolism: Improvement of Observer Agreement by the Use of a Lung Segment Reference Chart

J. Hirsh, J. T. ten Cate, G. Coates, 1992, Thrombosis and Haemostasis.

Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.

T. van der Poll, J. T. ten Cate, B. Biemond, 1998, American journal of respiratory and critical care medicine.

Complete Inhibition of Endotoxin-Induced Coagulation Activation in Chimpanzees with a Monoclonal Fab Fragment against Factor VII/VIIa

T. van der Poll, H. Büller, J. T. ten Cate, 1995, Thrombosis and Haemostasis.

Antithrombin Acts as a Negative Acute Phase Protein as Established with Studies on HepG2 Cells and in Baboons

R. W. Niessen, J. T. ten Cate, C. Hack, 1997, Thrombosis and Haemostasis.

The function of the human factor V carbohydrate moiety in blood coagulation.

J. T. ten Cate, A. Sturk, T. Bruin, 1987, European journal of biochemistry.

Diagnosis of venous thrombosis.

H. Büller, J. T. ten Cate, H. Heijboer, 1991, Seminars in thrombosis and hemostasis.

Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.

H. Büller, J. T. ten Cate, H. R. Büller, 1989, The American journal of medicine.

Diagnosis of deep vein thrombosis.

J. T. ten Cate, E. Van Beek, M. Koopman, 1994, Progress in cardiovascular diseases.

Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration.

T. van der Poll, J. T. ten Cate, S. V. van Deventer, 1997, Journal of immunology.

Results of a Multicenter Study Assessing the Status of Standardization of a Recombinant Thromboplastin for the Control of Oral Anticoagulant Therapy

J. T. ten Cate, P. Mannucci, L. Poller, 1994, Thrombosis and Haemostasis.

Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.

J. T. ten Cate, R. Coronel, M. Janse, 1995, Circulation.

Tumor Necrosis Factor Induces von Willebrand Factor Release in Healthy Humans

T. van der Poll, H. Büller, J. T. ten Cate, 1992, Thrombosis and Haemostasis.

Tissue plasminogen activator activity and inhibition in acute myocardial infarction and angiographically normal coronary arteries.

J. T. ten Cate, F. Verheugt, A. Sturk, 1987, The American journal of cardiology.

The clinical course of patients with suspected pulmonary embolism.

P. Bossuyt, H. Büller, J. T. ten Cate, 1997, Archives of internal medicine.

Clinical applications of new antithrombotic agents

J. T. ten Cate, H. ten Cate, R. Beijering, 1996, Annals of Hematology.

Antithrombin III. II. Comparison of different substrates and thrombin preparations.

J. T. ten Cate, C. Jenkins, L. Kahlé, 1978, Thrombosis research.

Comparison of the early dynamics of systemic prostacyclin release after administration of tumor necrosis factor and endotoxin to healthy humans.

T. van der Poll, H. Büller, J. T. ten Cate, 1991, The Journal of infectious diseases.

A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.

H. Büller, J. T. ten Cate, H. ten Cate, 1985, The Journal of laboratory and clinical medicine.

Studies on the Mechanism of Ristocetin‐induced Platelet Aggregation: Binding of Factor VIII to Platelets

J. T. ten Cate, A. Sturk, C. Jenkins, 1979, British journal of haematology.

Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees

T. van der Poll, J. T. ten Cate, S. V. van Deventer, 1994, The Journal of experimental medicine.

Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.

T. van der Poll, J. T. ten Cate, S. Deventer, 1993, The Journal of infectious diseases.

Endotoxin testing in blood.

J. T. ten Cate, A. Sturk, L. Thomas, 1987, Progress in clinical and biological research.

No evidence for a prethrombotic state in stable chronic inflammatory bowel disease.

J. T. ten Cate, G. Tytgat, E. Knot, 1983, Journal of clinical pathology.

Comparison of the early dynamics of coagulation activation after injection of endotoxin and tumor necrosis factor in healthy humans.

T. van der Poll, H. Büller, J. T. ten Cate, 1991, Progress in clinical and biological research.

Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits.

J. T. ten Cate, P. Charlton, A. V. van Zonneveld, 1997, Circulation.

Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo.

M. Koschinsky, H. Büller, J. T. ten Cate, 1997, Circulation.

Increased plasma levels of PAI-1 after administration of nonionic contrast medium in patients undergoing pulmonary angiography.

E. V. van Beek, H. Büller, J. T. ten Cate, 1994, Radiology.

Reliable Rapid Blood Test for the Exclusion of Venous Thromboembolism in Symptomatic Outpatients

H. Büller, J. T. ten Cate, E. Van Beek, 1997, Thrombosis and Haemostasis.

Spontaneous Platelet Aggregation in Cerebrovascular Disease II

J. T. ten Cate, J. Vos, E. V. van Wijk, 1979, Thrombosis and Haemostasis.

Effects of Standard Heparin and a Low Molecular Weight Heparin (Kabi 2165) on Fibrinolysis

J. T. ten Cate, G. Agnelli, B. Cosmi, 1988, Thrombosis and Haemostasis.

Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.

T. van der Poll, H. Büller, J. T. ten Cate, 1994, Blood.

Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

H. Büller, J. T. ten Cate, S. Deventer, 1990, Blood.

Effects on leukocytes after injection of tumor necrosis factor into healthy humans.

T. van der Poll, H. Büller, J. T. ten Cate, 1992, Blood.

A Double Blind Three Center Clinical Trial on the Short-Term Efficacy of 0-(β-Hydroxyethyl)-Rutosides in Patients with Post-Thrombotic Syndrome

J. T. ten Cate, M. Huisman, J. Jonker, 1989, Thrombosis and Haemostasis.

Inter‐individual variation in half‐life of infused recombinant factor VIII is related to pre‐infusion von Willebrand factor antigen levels

J. T. ten Cate, K. Fijnvandraat, M. Peters, 1995, British journal of haematology.

Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia.

T. van der Poll, J. T. ten Cate, S. Deventer, 1997, Blood.

The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.

J. T. ten Cate, J. V. van Mourik, J. Voorberg, 1997, Blood.

SYNTHESIS OF PLATELET ACTIVATING FACTOR BY HUMAN BLOOD PLATELETS

J. T. ten Cate, A. Sturk, H. van den Bosch, 1989, Thrombosis and Haemostasis.

Recent Advances in the Treatment of Venous Thromboembolism: Implications for the Next Century

H. Büller, J. T. ten Cate, 1998, Journal of the Royal College of Physicians of Edinburgh.

Deep Vein Thrombosis in Obstetric Patients: Diagnosis and Risk Factors

H. Büller, J. T. ten Cate, M. Levi, 1992, Thrombosis and Haemostasis.

A New Computerized Impedance Plethysmograph: Accuracy in the Detection of Proximal Deep-Vein Thrombosis in Symptomatic Outpatients

H. Büller, J. T. ten Cate, P. Prandoni, 1991, Thrombosis and Haemostasis.

Failure of Computerized Impedance Plethysmography in the Diagnostic Management of Patients with Clinically Suspected Deep-Vein Thrombosis

H. Büller, J. T. ten Cate, P. Prandoni, 1991, Thrombosis and Haemostasis.

Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis.

H. Büller, J. T. ten Cate, M. Huisman, 1988, Archives of internal medicine.

Evaluation of impedance plethysmography as a single non-invasive test for the diagnosis of clinically suspected deep vein thrombosis.

H. Büller, J. T. ten Cate, M. Huisman, 1984, The Netherlands journal of medicine.

Use of a Heparin Nomogram for Treatment of Patients with Venous Thromboembolism in a Community Hospital

H. Büller, J. T. ten Cate, M. van Marwijk Kooy, 1998, Thrombosis and Haemostasis.

Low Prevalence of Coagulation and Fibrinolytic Activation in Patients with Primary Untreated Cancer

H. Büller, J. T. ten Cate, C. Veenhof, 1990, Thrombosis and Haemostasis.

Differential Display Identification of 40 Genes with Altered Expression in Activated Human Smooth Muscle Cells

J. T. ten Cate, C. D. de Vries, A. Horrevoets, 2000, The Journal of Biological Chemistry.

Endotoxin-induced cytokines in human septicemia.

J. T. ten Cate, S. V. van Deventer, A. Sturk, 1990, Advances in experimental medicine and biology.

Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.

J. T. ten Cate, P. Borst, R. Schutgens, 1987, The Journal of clinical investigation.

Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis.

H. Büller, J. T. ten Cate, B. Biemond, 1996, Circulation.

Antithrombin III metabolism in two colitis patients with acquired antithrombin III deficiency.

J. T. ten Cate, G. Tytgat, E. Knot, 1985, Gastroenterology.

Variable Effects of Radiological Contrast Media on Thrombus Growth in a Rabbit Jugular Vein Thrombosis Model

J. T. ten Cate, B. Biemond, M. Levi, 1991, Thrombosis and Haemostasis.

Diagnosis of clinically suspected pulmonary embolism: a survey of current practice in a teaching hospital.

H. Büller, J. T. ten Cate, E. Van Beek, 1994, The Netherlands journal of medicine.

Coagulation and fibrinolytic factors in the first week of life in healthy infants.

J. T. ten Cate, M. Peters, C. Breederveld, 1985, The Journal of pediatrics.

Persistent antithrombin III deficiency: risk factor for thromboembolic complications in neonates small for gestational age.

J. T. ten Cate, M. Peters, J. Cate, 1984, The Journal of pediatrics.

Factors involved in early in vitro endotoxin hyporesponsiveness in human endotoxemia

T. Moojen, J. T. ten Cate, S. V. van Deventer, 1996 .

Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.

J. T. ten Cate, M. Daha, J. Verhoef, 1985, The Journal of infectious diseases.

Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans.

T. van der Poll, J. T. ten Cate, S. Lowry, 1997, Blood.

Erythrocyte-bound interleukin-8 and RANTES in human endotoxemia

R. D. de Winter, J. T. ten Cate, S. V. van Deventer, 1997 .

Analytical and clinical evaluation of commercial protein C assays.

H. Büller, J. T. ten Cate, J. Borm, 1987, Clinica chimica acta; international journal of clinical chemistry.

The Risk of Abortion and Stillbirth in Antithrombin-, Protein C-, and Protein S-deficient Women

J. T. ten Cate, P. Simioni, A. Girolami, 1996, Thrombosis and Haemostasis.

Spontaneous Platelet Aggregation in Cerebrovascular Disease

J. T. ten Cate, T. Cate, J. Vos, 1978, Thrombosis and Haemostasis.

Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis

H. Büller, J. T. ten Cate, J. V. van Mourik, 1996, British journal of haematology.

The Effectiveness of a Low Molecular Weight Heparinoid in Chronic Intermittent Haemodialysis

H. Büller, J. T. ten Cate, H. ten Cate, 1985, Thrombosis and Haemostasis.

Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.

J. T. ten Cate, D. Hoppensteadt, J. Fareed, 1991, Seminars in thrombosis and hemostasis.

Mechanical prophylaxis of deep vein thrombosis.

J. T. ten Cate, M. Huisman, M. Nurmohamed, 1991, Seminars in thrombosis and hemostasis.

Inhibition of extrinsic coagulation activation in endotoxemia; therapeutic implications.

T. van der Poll, J. T. ten Cate, S. V. van Deventer, 1994, Progress in clinical and biological research.

Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.

H. Büller, J. T. ten Cate, C. Hack, 1991, The Journal of clinical investigation.

Vinculin is a permanent component of the membrane skeleton and is incorporated into the (re)organising cytoskeleton upon platelet activation.

J. T. ten Cate, A. Sturk, J. Wilkinson, 1990, European journal of biochemistry.

Thrombin-Antithrombin III Complexes in the Prediction of Deep Vein Thrombosis Following Total Hip Replacement

H. Büller, J. T. ten Cate, A. Sturk, 1989, Thrombosis and Haemostasis.

A comparison of impedance plethysmography and strain gauge plethysmography in the diagnosis of deep venous thrombosis in symptomatic outpatients.

H. Büller, J. T. ten Cate, M. Huisman, 1985, Thrombosis research.

Impaired Haemostasis by Intravenous Administration of a Gelatin-based Plasma Expander in Human Subjects

J. T. ten Cate, E. de Jonge, A. van der Ende, 1998, Thrombosis and Haemostasis.

Cytokines: Triggers of Clinical Thrombotic Disease

T. van der Poll, J. T. ten Cate, S. Deventer, 1997, Thrombosis and Haemostasis.

Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression

J. T. ten Cate, M. Levi, P. Snel, 2001, Alimentary pharmacology & therapeutics.

Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.

J. T. ten Cate, W. Weimar, M. Levi, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.

J. T. ten Cate, W. Weimar, J. Ijzermans, 1999, Transplantation proceedings.

Endotoxin induced coagulation activation and protein C reduction in meningococcal septic shock.

J. T. ten Cate, S. V. van Deventer, K. Fijnvandraat, 1994, Progress in clinical and biological research.

Confirmation of the Failure of Computerized Impedance Plethysmography in the Diagnostic Management of Patients with Clinically Suspected Deep-Vein Thrombosis

H. Büller, J. T. ten Cate, P. Prandoni, 1991, Thrombosis and Haemostasis.

Parenteral nutrition facilitates activation of coagulation but not of fibrinolysis during human endotoxemia.

T. van der Poll, J. T. ten Cate, S. Lowry, 1998, The Journal of infectious diseases.

Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.

H. Büller, J. T. ten Cate, H. A. Otten, 2009, Scandinavian journal of haematology.

[Thrombosis diagnosis in Noord-Holland in 1985].

H. Büller, J. T. ten Cate, M. Levi, 1986, Nederlands tijdschrift voor geneeskunde.

Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma.

J. T. ten Cate, J. Borm, A. Sturk, 1988, Clinical chemistry.

Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.

H. Büller, J. T. ten Cate, H. ten Cate, 1985, Thrombosis research.

Thrombosis Prophylaxis in an AT III Deficient Pregnant Woman: Application of a Low Molecular Weight Heparinoid

H. Büller, J. T. ten Cate, H. ten Cate, 1986, Thrombosis and Haemostasis.

Deep Vein Thrombosis and Fibrinolysis

H. Büller, J. T. ten Cate, P. Prandoni, 1991, Thrombosis and Haemostasis.

Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients. A comparison with standard heparin.

J. T. ten Cate, M. Nurmohamed, J. Hoek, 1991, ASAIO transactions.

Recombinant, B-domain Deleted Factor VIII (r-VIII SQ): Pharmacokinetics and Initial Safety Aspects in Hemophilia A Patients

J. T. ten Cate, J. Spira, M. Peters, 1997, Thrombosis and Haemostasis.

Purified radiolabeled antithrombin III metabolism in three families with hereditary AT III deficiency: application of a three-compartment model.

J. T. ten Cate, E. Knot, T. Bruin, 1986, Blood.

Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.

J. T. ten Cate, A. Sturk, M. Schaap, 1985, Thrombosis research.

Effects of extradural bupivacaine on the haemostatic system.

J. T. ten Cate, N. F. Dabhoiwala, H. ten Cate, 1986, British Journal of Anaesthesia.

Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study.

H. Büller, J. T. ten Cate, E. Van Beek, 1994, Netherlands Journal of Medicine.

Acquired alpha‐2‐antiplasmin deficiency in acute promyelocytic leukaemia

J. T. ten Cate, F. Mandelli, G. Avvisati, 1988, British journal of haematology.

Quantitative Endotoxin Determination In Blood With A Chromogenic Substrate

J. T. ten Cate, H. ten Cate, A. Sturk, 1981, Thrombosis and Haemostasis.

Postoperative hemostatic profile in relation to gram‐negative septicemia

H. Büller, J. T. ten Cate, C. Bolwerk, 1982, Critical care medicine.

Antithrombin III deficiency in surgical intensive care patients.

J. T. ten Cate, H. Schipper, J. Roos, 1981, Thrombosis research.

Enhanced thrombin generation in normal and hypertensive pregnancy.

J. T. ten Cate, J. Borm, A. Sturk, 1989, American journal of obstetrics and gynecology.

Lumbar arterial rupture secondary to iliopsoas hemorrhage in a hemophiliac patient.

J. T. ten Cate, C. Henny, J. W. Marsman, 1984, Acta haematologica.

A human alloantibody interferes with binding of factor IXa to the factor VIII light chain.

J. T. ten Cate, J. V. van Mourik, J. Voorberg, 1998, Blood.

Factor VIII Inhibitor Associated with Ciprofloxacin

J. T. ten Cate, E. Van Beek, Marjolein Peters, 1993, Thrombosis and Haemostasis.

DDAVP Induces Systemic Release of Urokinase-Type Plasminogen Activator

J. T. ten Cate, G. Agnelli, G. Dooijewaard, 1989, Thrombosis and Haemostasis.

Review: infectious diseases and coagulation disorders.

J. T. ten Cate, J. V. D. van der Meer, H. ten Cate, 1999, The Journal of infectious diseases.

Vitamin-K status beyond the neonatal period

N. Nagelkerke, J. T. ten Cate, H. Heymans, 1986, European Journal of Pediatrics.

The synthesis, catabolism, and pathophysiological role of platelet-activating factor.

J. T. ten Cate, D. Hosford, P. Braquet, 1989, Advances in lipid research.

Antithrombin III metabolism in patients with liver disease.

J. T. ten Cate, G. Tytgat, E. Knot, 1984, Journal of clinical pathology.

Management of disseminated intravascular coagulation in obstetrics.

H. Büller, J. T. ten Cate, D. Brandjes, 1991, European Journal of Obstetrics, Gynecology, and Reproductive Biology.

Validity of the endotoxin assay in post surgical patients.

H. Büller, J. T. ten Cate, A. Sturk, 1985, Progress in clinical and biological research.

A review of the importance of acute multidisciplinary treatment following spontaneous rupture of the liver capsule during pregnancy.

J. T. ten Cate, H. Buller, W. H. Brummelkamp, 1983, Surgery, gynecology & obstetrics.

The Effect of Different Anaesthetic Techniques on the Incidence of Thrombosis following Total Hip Replacement

J. T. ten Cate, H. ten Cate, M. Nurmohamed, 1991, Thrombosis and Haemostasis.

Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants.

J. T. ten Cate, E. V. van Wijk, L. Kahlé, 1980, Clinical chemistry.

Antithrombin III. I. Evaluation of an automated antithrombin III method.

J. T. ten Cate, H. Schipper, C. Jenkins, 1978, Thrombosis research.

Antithrombin III transfusion in patients with hepatic cirrhosis

J. T. ten Cate, H. Schipper, 1982, British journal of haematology.

Increased Plasminogen Activator Inhibition Levels in Malignancy

J. T. ten Cate, G. Dooijewaard, D. Rijken, 1987, Thrombosis and Haemostasis.

Antithrombin III Infusion in Patients Undergoing Peritoneovenous Shunt Operation: Failure in the Prevention of Disseminated Intravascular Coagulation

H. Büller, J. T. ten Cate, 1983, Thrombosis and Haemostasis.

Rapid microanalysis of coagulation parameters by automated chromogenic substrated methods - application in neonatal patients.

J. T. ten Cate, M. Peters, L. Kahlé, 1982, Thrombosis research.

Acquired factor XII Deficiency in a patient with nephrotic syndrome.

J. T. ten Cate, E. V. van Royen, J. Wilmink, 2009, Acta Medica Scandinavica.

Further evaluation of an automated amidolytic factor X assay in monitoring anti-vitamin K treatment.

J. T. ten Cate, E. V. van Wijk, L. Kahlé, 2009, Scandinavian journal of haematology.

A rapid manual chromogenic factor X assay.

J. T. ten Cate, E. V. van Wijk, L. Kahlé, 1981, Thrombosis research.

Daily monitoring of Antithrombin III in premature neonates.

J. T. ten Cate, C. Breederveld, M. Peters, 1982, Acta chirurgica Scandinavica. Supplementum.

Intestinal endotoxemia. Clinical significance.

J. T. ten Cate, G. Tytgat, S. V. van Deventer, 1988, Gastroenterology.

Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.

T. van der Poll, J. T. ten Cate, S. Deventer, 1993, Journal of immunology.

Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia.

T. van der Poll, J. T. ten Cate, S. V. van Deventer, 1994, The Journal of infectious diseases.

Interleukin-6 mediates host defense responses induced by abdominal surgery.

H. Büller, J. T. ten Cate, S. V. van Deventer, 1993, Surgery.

The influence of epidural analgesia on platelet function and correlation with plasma bupivacaine concentrations.

J. T. ten Cate, A. Sturk, J. Bovill, 1988, European journal of anaesthesiology.

Antithrombin-III Transfusion in Patients with Liver Cirrhosis

J. T. ten Cate, R. Lamping, H. Schipper, 1979, Thrombosis and Haemostasis.

Optimization of a mechanized amidolytic factor-X assay; influence of reaction conditions and reagents.

J. T. ten Cate, E. V. van Wijk, L. Kahlé, 1981, Clinical chemistry.

Generation of a thrombin-like activity in late pregnancy.

J. T. ten Cate, E. V. van Royen, 1976, Thrombosis research.

alpha 2-Plasmin inhibitor metabolism in patients with liver cirrhosis.

J. T. ten Cate, E. Knot, E. de Jong, 1985, The Journal of laboratory and clinical medicine.

Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.

T. van der Poll, H. Büller, J. T. ten Cate, 1995, Clinical science.

Randomized Double-Blind, Placebo Controlled Safety Study of a Low Molecular Weight Heparinoid in Patients Undergoing Transurethral Resection of the Prostate

J. T. ten Cate, H. ten Cate, C. Henny, 1987, Thrombosis and Haemostasis.

Heparin versus low molecular weight heparin K 2165 in chronic hemodialysis patients: a randomized cross-over study.

J. T. ten Cate, J. Borm, A. Sturk, 1986, Haemostasis.

Automated amidolytic method for determining heparin, a heparinoid, and a low-Mr heparin fragment, based on their anti-Xa activity.

J. T. ten Cate, H. ten Cate, R. Lamping, 1984, Clinical chemistry.

Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery

H. Büller, J. T. ten Cate, M. Gent, 1996, Thrombosis and Haemostasis.

ACQUIRED RISK FACTORS AND DEEP VEIN THROMBOSIS IN SYMPTOMATIC OUT PATIENTS

J. T. ten Cate, P. Prandoni, E. Bernardi, 1994, Thrombosis and Haemostasis.

Identification of a contaminant protein in the purification of human factor V. Comparison of two purification methods.

J. T. ten Cate, A. Sturk, T. Bruin, 1983, Biochimica et biophysica acta.

Isolation and partial characterization of human factor V.

J. T. ten Cate, T. Hakvoort, P. Bolhuis, 1979, Biochimica et biophysica acta.

Additive Effect of dDAVP and Standard Heparin inIncreasing Plasma t-PA

J. T. ten Cate, G. Agnelli, B. Cosmi, 1989, Thrombosis and Haemostasis.

Quantitative chromogenic endotoxin determination in cerebrospinal fluid.

J. T. ten Cate, H. ten Cate, A. Sturk, 1983, Clinica chimica acta; international journal of clinical chemistry.

Early Markers of Blood Coagulation and Fibrinolysis Activation in Argentine Hemorrhagic Fever

J. T. ten Cate, C. Hack, J. Maiztegui, 1995, Thrombosis and Haemostasis.

Hemostasis, Thrombosis, and Vascular Biology Vascular Endothelial Genes That Are Responsive to Tumor Necrosis Factor-␣ in Vitro Are Expressed in Atherosclerotic Lesions, including Inhibitor of Apoptosis Protein-1, Stannin, and Two Novel Genes

J. T. ten Cate, A. V. van Zonneveld, C. D. de Vries, 1998 .

Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.

M. Prins, H. Büller, J. T. ten Cate, 1999, Archives of internal medicine.

Detection of Carriers in Glanzmann's Thrombasthenia

J. T. ten Cate, A. Sturk, E. van Leeuwen, 1983, Thrombosis and Haemostasis.

Detection and clinical relevance of human endotoxemia.

H. Büller, J. T. ten Cate, S. V. van Deventer, 1990, Zeitschrift fur medizinische Laboratoriumsdiagnostik.

Optimalization of a chromogenic assay for endotoxin in blood.

J. T. ten Cate, A. Sturk, L L Thomas, 1985, Progress in clinical and biological research.

Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.

T. van der Poll, J. T. ten Cate, S. Deventer, 1994, Journal of immunology.

Hereditary AT III deficiency and heparin.

H. Büller, J. T. ten Cate, C. Bolwerk, 1982, Thrombosis research.

Treatment of Venous Thromboembolism

J. T. ten Cate, M. Koopman, H. Büller, 1995, Thrombosis and Haemostasis.

Tumor Necrosis Factor Induces von Willebrand Factor Release in Healthy Humans

T. van der Poll, J. T. ten Cate, G. Pasterkamp, 1992, Thrombosis and Haemostasis.

Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis.

M. Prins, H. Büller, J. T. ten Cate, 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis.

H R Büller, H. Büller, J. T. ten Cate, 1992, The New England journal of medicine.

Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia

M. Prins, H. Büller, J. T. ten Cate, 1999, Thrombosis and Haemostasis.

Interleukin 10 Release During Endotoxaemia in Chimpanzees: Role of Platelet‐Activating Factor and Interleukin 6

T. van der Poll, J. T. ten Cate, C. Hack, 1996, Scandinavian journal of immunology.

Partial in vivo neutralisation of plasma anticoagulant effects of Lomoparan (Org 10172) by protamine chloride.

J. T. ten Cate, H. ten Cate, T. van Dinther, 1991, Thrombosis research.

Antigen biological activity ratio for factor VIII in late pregnancy.

J. T. ten Cate, E. V. van Royen, 1973, Lancet.

Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.

J. T. ten Cate, F. Mandelli, G. Avvisati, 1985, Scandinavian journal of clinical and laboratory investigation. Supplementum.

SILENT PULMONARY EMBOLISM IN PATIENTS WITH DEEP VEIN THROMBOSIS

J. T. ten Cate, J. Vreeken, M. Huisman, 1987, Thrombosis and Haemostasis.

IMPAIRED FIBRINOLYSIS IN CYCLOSPORINE‐TREATED RENAL TRANSPLANT PATIENTS ANALYSIS OF THE DEFECT AND BENEFICIAL EFFECT OF FISH‐OIL

H. Büller, J. T. ten Cate, M. Levi, 1992, Transplantation.

Endotoxemia, bacteremia and urosepsis.

H. Büller, J. T. ten Cate, S. V. van Deventer, 1988, Progress in clinical and biological research.

Purification of Human Factor

J. T. ten Cate, T. Hakvoort, K. Breederveld, 1977, Thrombosis and Haemostasis.

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.

C. Sprung, J. T. ten Cate, S. V. van Deventer, 1992, The Journal of infectious diseases.

Endotoxins in portal blood.

J. T. ten Cate, S. V. van Deventer, A. Sturk, 1988, Hepato-gastroenterology.

Clinical Utility of Real-Time Compression Ultrasonography for Diagnostic Management of Patients with Recurrent Venous Thrombosis

H. Büller, J. T. ten Cate, H. Heijboer, 1992, Acta radiologica.

Contrast Venography, the Gold Standard for the Diagnosis of Deep-Vein Thrombosis: lmprovement in Observer Agreement

J. T. ten Cate, P. Prandoni, A. Cogo, 1992, Thrombosis and Haemostasis.

Antithrombin-III: clinical significance.

J. T. ten Cate, 1982, Acta chirurgica Scandinavica. Supplementum.

Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23).

J. T. ten Cate, S. V. van Deventer, M. Levi, 1995, Blood.

Factor XIa Induced Activation of the Intrinsic Cascade In Vivo

J. T. ten Cate, C. Hack, B. Biemond, 1996, Thrombosis and Haemostasis.

Biological activity of a semisynthetic flavonoid, O-( -hydroxyethyl)rutoside: light-scattering and metabolic studies of human red cells and platelets.

J. T. ten Cate, N. V. van Haeringen, E. Glasius, 1973, Clinical chemistry.

The Determination of Factor X Using an Automated Amidolytic Technique

J. T. ten Cate, E. V. van Wijk, L. Kahlé, 1979, Thrombosis and Haemostasis.

Anticoagulants and Extracorporeal Circuits

J. T. ten Cate, R. Beijering, H. Cate, 1997, Seminars in thrombosis and hemostasis.

Detection of deep-vein thrombosis by real-time B-mode ultrasonography.

H. Büller, J. T. ten Cate, P. Prandoni, 1989, The New England journal of medicine.

[Diagnostic management in suspicion of pulmonary embolism: results of a survey among Dutch internists and pulmonologists].

H. Büller, J. T. ten Cate, E. V. van Royen, 1992, Nederlands tijdschrift voor geneeskunde.

Randomised evaluation of treatment modalities in thromboembolic disorders.

H. Büller, J. T. ten Cate, 1999, Haematologica.

Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures.

H. Büller, J. T. ten Cate, H. ten Cate, 1984, American journal of clinical pathology.

Endotoxin-induced neutrophil activation--the role of complement revisited.

J. T. ten Cate, C. Hack, L. Thijs, 1991, Progress in clinical and biological research.

Fibrinolytic Response to lnterferon-a in Healthy Human Subjects

J. T. ten Cate, J. Romijn, C. Hack, 1996, Thrombosis and Haemostasis.